Doris Bach

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

R. Loch Macdonald, Randall T. Higashida, E. Keller et al. · The Lancet Neurology · 2011 · 625 citations

Placebo-controlled Phase 3, Endovascular Technique, Vascular Surgery +5

A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip Replacement

Bengt I. Eriksson, Peter Kälebo, Patrick Mouret et al. · New England Journal of Medicine · 1997 · 371 citations · Full text

Randomized Trial of Clazosentan in Patients With Aneurysmal Subarachnoid Hemorrhage Undergoing Endovascular Coiling

R. Loch Macdonald, Randall T. Higashida, E. Keller et al. · Stroke · 2012 · 323 citations · Full text

[Validation of the German version of the 20-item Toronto Alexithymia Scale in normal persons and psychiatric patients].

Michael Bach, Doris Bach, de Zwaan M et al. · PubMed · 1996 · 181 citations

Psychiatric Evaluation, Mental Health, Psychology +19

Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393

Bengt I. Eriksson, P Kälebo, B Zachrisson et al. · The Lancet · 1996 · 176 citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +13